Aprecap 150mg Injection
By Aprecap
Rx
1 Injection in a Vial

Composition
Aprepitant(150mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
September, 2025

liver
Aprecap 150mg Injection is considered safe for individuals with liver disease based on available data. It appears that adjusting the dosage of Aprecap 150mg Injection may not be necessary for patients with liver issues. However, it is advisable to consult with your healthcare provider before using this medication to ensure its safety and effectiveness.

kidney
Aprecap 150mg Injection is safe for patients with kidney disease. No dose adjustment is needed for Aprecap 150mg Injection in such patients.

alcohol
Consult your doctor when consuming alcohol with Aprecap 150mg Injection.

driving
Aprecap 150mg Injection may reduce alertness, impair vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Aprecap 150mg Injection should be used with caution during pregnancy. Limited human studies show potential harm to the developing baby, as indicated by animal studies. Your doctor will evaluate the benefits versus risks before prescribing this medication. Please consult your doctor.

breastfeeding
Aprecap 150mg Injection is likely unsafe to use while breastfeeding. Limited data indicates it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Phenylmorpholine Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | NK1 Antagonists |
₹2277
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024